We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Incyte Corporation | NASDAQ:INCY | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.67 | 1.26% | 53.76 | 50.05 | 54.50 | 53.87 | 52.73 | 53.70 | 1,407,391 | 01:00:00 |
Among the companies with shares expected to trade actively in Monday's session are MoneyGram International Inc. (MGI), Eli Lilly & Co. (LLY), and Incyte Corp. (INCY)
Ant Financial Services Group has raised its bid for U.S. money-transfer company MoneyGram International to around $1.2 billion--topping a rival offer and making China's biggest online-payments firm once more the leading contender in an increasingly politicized takeover battle. Shares of MoneyGram climbed 8.2% to $17.87 in premarket trading.
Eli Lilly and Incyte on Friday said the U.S. Food and Drug Administration didn't approve their new drug application for a rheumatoid arthritis treatment that some analysts estimate could generate more than $2 billion in annual sales. Shares of Lilly dropped 5.5% to $81.10 premarket Monday, while Incyte shares sank 11% to $126.03.
Snyder's-Lance Inc. (LNCE) said Monday that Chief Executive Carl Lee Jr. has retired after 12 years at the company, and the maker of Kettle Brand and Cape Cod chips braced investors for weakness going forward. The company's shares tumbled 12% to $35.05 premarket.
Hospital operator HCA Holdings Inc. (HCA) posts preliminary quarterly results below Wall Street expectations, blaming shifts in payer mix as well one fewer day in the period compared to last year.
Write to Jenny Roth at jenny.roth@wsj.com
(END) Dow Jones Newswires
April 17, 2017 09:26 ET (13:26 GMT)
Copyright (c) 2017 Dow Jones & Company, Inc.
1 Year Incyte Chart |
1 Month Incyte Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions